Gender dysphoria (GD) involves a mismatch between an individual’s experienced gender and their assigned gender at birth (
1). Global prevalence data are limited, with incidence rates varying across countries due to cultural factors that influence the presentation and distress associated with GD (
2). Studies estimate the prevalence of male-to-female (MTF) transsexuals to range from 1:11,900 to 1:45,000, and female-to-male (FTM) transsexuals from 1:30,400 to 1:200,000 (
3,
4). Diagnoses of GD in individuals assigned male and female at birth have increased over the past decade, altering the sex ratio (
5,
6). In 1987, Iran legalized sex reassignment surgery (SRS) for individuals with GD, requiring permits from the Forensic Medicine Organization (FMO) (
7). Iran was the first country in the Middle East and the second worldwide, after Thailand, to perform SRS (
8). However, little is known about the annual number of individuals seeking or receiving this treatment.